Erica Mayer, MD, MPH

Medical Oncology

Erica Mayer, MD, MPH

View full profile

Related Videos

Erica Mayer, MD discusses results from TBCRC 56 study Video

Erica Mayer, MD discusses results from TBCRC 56 study

Erica Mayer, MD, of Dana-Farber Cancer Institute shared results from TBCRC 56, showing presurgical treatment with a PARP inhibitor + anti-PD1 combo in patients with gBRCAm early triple-negative breast cancer resulted in a pCR rate of 50%. ...

ESMO25 Breast Cancer Highlights: evERA and SERENA6 Video

ESMO25 Breast Cancer Highlights: evERA and SERENA6

Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH, discuss the evERA and SERENA6 trials investigating oral selective estrogen receptor degraders (SERDs).

TRADE Study Presented by Erica Mayer, MD. Video

TRADE Study Presented by Erica Mayer, MD.

Dr. Erica Mayer shares results from the TRADE study showing a successful abemaciclib dose escalation strategy in patients with HR+ breast cancer.

Adjuvant Palbociclib in HR+/HER2 Early Breast Cancer - Final results from PALLAS Trial Video

Adjuvant Palbociclib in HR+/HER2 Early Breast Cancer - Final results from PALLAS Trial

Dana-Farber's Erica Mayer, MD, MPH discusses the final analysis of the International Phase 3 PALLAS clinical trial presented at the 2021 San Antonio Breast Cancer Symposium.